Literature DB >> 3666964

Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation.

R da Silva1, D L Sacks.   

Abstract

The in vivo virulence patterns of promastigote populations defined on the basis of agglutination by the lectin peanut agglutinin (PNA) were studied for various cloned lines of Leishmania major. Promastigotes derived from logarithmic-phase cultures, which were routinely 100% agglutinated at 100 micrograms of PNA per ml, were relatively avirulent for BALB/c mice. The relative virulence of stationary-phase promastigotes appeared to be attributable to the proportion of nonagglutinable (PNA-) promastigotes contained within these populations. Purification of PNA- organisms from stationary cultures provided for each clone the most virulent inoculum, supporting the view that this change in lectin binding accurately reflects the development of infective metacyclic stage promastigotes. By studying this marker, we found that there was considerable variation in the degree to which different strains and clones underwent metacyclogenesis during growth. Examination of a reportedly avirulent L. major clone revealed that metacyclogenesis was unusually delayed and inefficient for this clone, but that those PNA- promastigotes which could be recovered from late-stationary-phase cultures were virulent for BALB/c mice. The loss of virulence associated with frequent subculture could also be attributed to a drastic diminution in metacyclogenesis potential over time. A clone which yielded over 90% PNA- promastigotes during growth within passage 1 generated fewer than 10% PNA- promastigotes during growth by passage 94. Subcloning of late-passage attenuated promastigotes yielded a clone for which no PNA- promastigotes could be generated during growth, and an infective population could not be derived from this clone. Thus, metacyclogenesis does not appear to be stable for even cloned lines of Leishmania promastigotes, and virulence comparisons between different strains and clones can be meaningfully made only if the metacyclic populations contained within the respective inocula are determined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666964      PMCID: PMC259980          DOI: 10.1128/iai.55.11.2802-2806.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.

Authors:  R A NEAL
Journal:  Ann Trop Med Parasitol       Date:  1964-12

2.  Infectivity of Leishmania donovani amastigotes and promastigotes for golden hamsters.

Authors:  J S Keithly
Journal:  J Protozool       Date:  1976-05

3.  Morphology and infectivity of Leishmania donovani cultivated in nonliving media at elevated temperatures.

Authors:  T Wonde; B M Honigberg
Journal:  Am J Trop Med Hyg       Date:  1971-11       Impact factor: 2.345

4.  Identification of an infective stage of Leishmania promastigotes.

Authors:  D L Sacks; P V Perkins
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

5.  Enzyme variation and difference in infectivity within a single strain of Leishmania mexicana mexicana.

Authors:  G Grimaldi; H Momen; M J Soares; P L Moriearty
Journal:  Int J Parasitol       Date:  1982-06       Impact factor: 3.981

6.  The surface membrane of Leishmania. I. The effects of lectins on different stages of Leishmania braziliensis.

Authors:  K Dawidowicz; A G Hernandez; R B Infante; J Convit
Journal:  J Parasitol       Date:  1975-10       Impact factor: 1.276

7.  Isolation and characterization of infective and non-infective clones of Leishmania tropica.

Authors:  E Handman; R E Hocking; G F Mitchell; T W Spithill
Journal:  Mol Biochem Parasitol       Date:  1983-02       Impact factor: 1.759

8.  A comparative study of different Leishmania tropica isolates from Iran: correlation between infectivity and cytochemical properties.

Authors:  A Ebrahimzadeh; T C Jones
Journal:  Am J Trop Med Hyg       Date:  1983-07       Impact factor: 2.345

9.  Phenotypic diversity of cloned lines of Leishmania major promastigotes.

Authors:  C L Greenblatt; E Handman; G F Mitchell; F L Battye; L F Schnur; D Snary
Journal:  Z Parasitenkd       Date:  1985

10.  Leishmania braziliensis: cell surface differences in promastigotes of pathogenic and nonpathogenic strains.

Authors:  C Ayesta; C Argüello; A G Hernández
Journal:  Exp Parasitol       Date:  1985-04       Impact factor: 2.011

View more
  73 in total

Review 1.  Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.

Authors:  Norikiyo Ueno; Mary E Wilson
Journal:  Trends Parasitol       Date:  2012-06-21

2.  Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.

Authors:  C Kébaïer; H Louzir; M Chenik; A Ben Salah; K Dellagi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum.

Authors:  Ger van Zandbergen; Annalena Bollinger; Alexander Wenzel; Shaden Kamhawi; Reinhard Voll; Matthias Klinger; Antje Müller; Christoph Hölscher; Martin Herrmann; David Sacks; Werner Solbach; Tamás Laskay
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle.

Authors:  A Cooper; H Rosen; J M Blackwell
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

5.  The role of phosphoglycans in Leishmania-sand fly interactions.

Authors:  D L Sacks; G Modi; E Rowton; G Späth; L Epstein; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi.

Authors:  M E Wilson; R W Vorhies; K A Andersen; B E Britigan
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Ascorbate peroxidase from Leishmania major controls the virulence of infective stage of promastigotes by regulating oxidative stress.

Authors:  Swati Pal; Subhankar Dolai; Rajesh K Yadav; Subrata Adak
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

8.  Linking in vitro and in vivo survival of clinical Leishmania donovani strains.

Authors:  Manu Vanaerschot; Ilse Maes; Meriem Ouakad; Vanessa Adaui; Louis Maes; Simonne De Doncker; Suman Rijal; François Chappuis; Jean-Claude Dujardin; Saskia Decuypere
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

9.  Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

Authors:  Geremew Tasew; Susanne Nylén; Thorsten Lieke; Befekadu Lemu; Hailu Meless; Nicolas Ruffin; Dawit Wolday; Abraham Asseffa; Hideo Yagita; Sven Britton; Hannah Akuffo; Francesca Chiodi; Liv Eidsmo
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

10.  Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern.

Authors:  Deborah E Dobson; Shaden Kamhawi; Phillip Lawyer; Salvatore J Turco; Stephen M Beverley; David L Sacks
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.